INS and type 2 diabetes mellitus: As insulin becomes an increasingly common treatment for patients with type 2 diabetes, [5] these findings highlight the critical need for studies of the comparative effects of continuing versus stopping insulin secretagogues and newer diabetes medications after insulin is started.